Memantina Aurobindo (Memantine Hydrochloride)

Memantine acts as a non‑competitive antagonist at NMDA receptors. By blocking excessive glutamate‑mediated calcium influx, it reduces excitotoxic neuronal damage while allowing normal synaptic activity, thereby supporting cognitive function in Alzheimer’s disease.

The dosage of Memantina Aurobindo is determined by the prescribing clinician based on the patient’s clinical condition, renal function, and response to therapy. Physicians set the appropriate dose and titration schedule for each individual.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA‑receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both classes aim to improve cognition, memantine targets excitotoxic pathways, and it is typically used in moderate to severe disease, often in combination with an acetylcholinesterase inhibitor for added benefit.

Memantina Aurobindo should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and extreme temperatures to maintain its stability and potency.

The medication is taken orally, usually as a tablet, with or without food. Patients should follow the prescribing physician’s instructions regarding timing and any dose adjustments.

Serious adverse events, although rare, include seizures, severe skin reactions such as Stevens‑Johnson syndrome, and hepatic dysfunction. Patients should be monitored for these signs and seek immediate medical attention if they occur.

Memantina Aurobindo is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is also advised for individuals with uncontrolled severe renal or hepatic impairment, and those taking other NMDA antagonists.